Ondine Biomedical Inc. (AIM:OBI)
United Kingdom · Delayed Price · Currency is GBP · Price in GBX 9.08
-0.38 (-3.97%)
Nov 6, 2026, 2:46 PM GMT
Ondine Biomedical Market Cap
Ondine Biomedical has a market cap or net worth of 50.93 million as of November 6, 2026. It is the 27,328th most valuable company in the world and the 606th biggest in the United Kingdom. Its market cap has decreased by 6.41% in one year.
Market Cap
50.93M
Enterprise Value
48.25M
Revenue
1.53M
Global Rank
Country Rank
#606 United Kingdom
PE Ratio
n/a
ChartMarket Cap Chart
Since December 6, 2021, Ondine Biomedical's market cap has decreased from 112.86M to 50.93M, a decrease of -54.87%. That is a compound annual growth rate of -14.93%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 50.93M | 31.03% |
| Dec 31, 2025 | 38.87M | 9.33% |
| Dec 31, 2024 | 35.55M | 79.20% |
| Dec 29, 2023 | 19.84M | -50.26% |
| Dec 30, 2022 | 39.89M | -63.06% |
| Dec 31, 2021 | 107.99M | -4.31% |
| Dec 6, 2021 | 112.86M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bioventix | 107.11M |
| Scancell Holdings | 104.74M |
| 4basebio | 77.69M |
| Faron Pharmaceuticals Oy | 62.99M |
| Poolbeg Pharma | 48.22M |
| Hemogenyx Pharmaceuticals | 43.52M |
| Arecor Therapeutics | 37.37M |
| IXICO | 33.37M |